| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |